• Guidance
  • Interesting shortcuts
  • EFFRA Members' Perspectives
  • News Dashboard
  • Structured Wiki
    • Search
    • FoF and Made in Europe Partnership
    • Demonstrators, pilots, prototypes
    • Exploitable result(s)
    • Significant innovations and lessons learned, training aspects
    • Report - Video - Presentation - Publication....?
    • Project clusters
    • EFFRA member perspectives
    • Manufacturing future products
    • Manufacturing performance characteristics
    • Technologies and enablers
    • ICT performance characteristics
    • Standards, technical committees and working groups
    • Contribution of R&I projects to standardisation
    • Regulatory and policy aspects
    • Standards - other classifications
    • Business model aspects
    • Pathways
    • MiE SRIA R&I Priorities
    • MiE WP26-27 Consultation - Potential Research Topics only
    • MiE WP26-27 Consultation and context pointers
    • MiE WP26-27 Consultation with pointers to WP25-27 consultation
    • MiE KPIs
    • Relevant (future) calls
    • EU-Programme-Call
    • NACE code
    • EFFRA Organisations - members
    • EFFRA WG pointers
  • Pathways
    • Pathways
  • Projects
    • Projects
  • Resources
    • Resources
  • Project ideas
    • Project ideas
  • People & organisations
    • People
    • Organisations
  • portal@effra.eu
  • Visit the EFFRA website
    • Login
  • Structured Wiki
  • EU-Programme-Call
  • Horizon 2020
  • H2020-EU.2. INDUSTRIAL LEADERSHIP
  • H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
  • H2020-EU.2.1.2. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies
  • H2020-EU.2.1.2.2. Ensuring the safe and sustainable development and application of nanotechnologies

H2020-EU.2.1.2.2. Ensuring the safe and sustainable development and application of nanotechnologies

  • H2020-NMBP-2016-two-stage
    • NMBP-26-2016 Analytical techniques and tools in support of nanomaterial risk assessment
  • H2020-NMBP-2017-two-stage
    • NMBP-14-2017 Regulatory Science Framework for assessment of risk benefit ratio of Nanomedicines and Biomaterials
    • NMBP-28-2017 Framework and strategies for nanomaterial characterisation, classification, grouping and read-across for risk analysis
    • NMBP-29-2017 Advanced and realistic models and assays for nanomaterial hazard assessment
  • H2020-NMBP-CSA-2016
    • NMBP-27-2016 Promoting safe innovation through global consolidation and networking of nanosafety centres and strengthening the European industry through cooperation in nanosafety
  • H2020-NMP-2014-two-stage
    • NMP-28-2014 Assessment of environmental fate of nanomaterials
  • H2020-NMP-2015-two-stage
    • NMP-29-2015 Increasing the capacity to perform nano-safety assessment
    • NMP-30-2015 Next generation tools for risk governance of nanomaterials
  • H2020-NMP-CSA-2014
    • NMP-27-2014 Coordination of EU and international efforts in safety of nanotechnology
  • H2020-NMP-PILOTS-2015
    • NMP-02-2015 Integration of novel nano materials into existing production lines
    • NMP-06-2015 Novel nanomatrices and nanocapsules
    • NMP-07-2015 Additive manufacturing for tabletop nanofactories
Powered by Chris Decubber BV